VinFast Delivers 58,577 EVs in Q1 2026, Up 61%, as It Builds Broader Green Mobility Ecosystem

Alphabet subsidiaries Waymo and Isomorphic Labs are pursuing major new funding moves in autonomous driving and AI drug discovery. Waymo has lined up US$5b in debt financing to support an international expansion of its robotaxi operations outside the US, while Isomorphic Labs is reported to be targeting a US$40b to US$50b valuation in its next capital raise focused on AI driven drug design. Waymo's US$5b term loan pushes more of Alphabet's AI buildout onto subsidiary-level borrowing rather than Alphabet's own cash, adding fixed obligations to a capital intensive project where timelines and regulatory paths are less clear than core Search or Cloud. Isomorphic Labs pursuing a US$40b to US$50b valuation highlights how far Alphabet is willing to stretch its AI ambitions beyond advertising and enterprise software, leaning into the reward side of future AI monetisation while magnifying the risk analysts flag around capital intensity and non cash earnings.

Yorkville Ives analyst Dan Ives reiterated his Outperform rating and $500 price target on Tesla, arguing autonomy, robotaxis and Optimus humanoid robots will increasingly drive the company's value. "We view Tesla as one of the clearest ways to own physical AI in the public markets," Ives wrote, adding that investors valuing Tesla primarily as an automaker are pricing a fleet rather than the platform being built on top of it. He calls Full Self-Driving the bridge between today's car business and tomorrow's autonomy business, with an attach rate above 55% on new North American EV sales, while Tesla's robotaxi service now operates in six US cities with paid miles approaching 2.5 million and a 5,000-vehicle Nevada permit gives it a path to a much larger fleet. Using a sum-of-the-parts valuation based on 2028 revenue estimates, Ives values Tesla's existing businesses at about $165 per share as a car company and assigns the remaining $335 to autonomy and Optimus, meaning roughly two-thirds of his price target rests on businesses still in their early stages. He flags risks including that only 45 Cybercabs are authorized for driverless operation in Texas, that Tesla expects about 2,500 vehicles in Nevada in year one, half of what the permit allows, and that NHTSA issued a Special Order on Cybercab's self-certification with Tesla's sworn response due September 30th.